Friday, 22 Jun 2018

You are here

The RheumNow Week in Review – Methotrexate CIRT Study (5.25.18)

Dr. Jack Cush reviews this past week's news from RheumNow.com - the risk of Cutaneous and Systemic LE, increasing flu vaccination, higher risk of VTE, MPO predictions, new drug for GIOP and CIRT - MTX in cardiovascular risk patients.

  1. Population study in Denmark shows the incidence of cutaneous LE to be 2.74/100,000 with a female:male ratio of 4:1 - the 10 year risk of these subsequently developing a dx of SLE was 12.9% (highest in women & SCLE pts) http://bit.ly/2IGoPQB
  2. Registry of 509 women with SLE had 719 children showed that compared to matched controls, children born to mothers with SLE had No greater risk of a systemic rheumatic autoimmune diagnoses. http://bit.ly/2GO37V0
  3. NEJM study of 1945 Kawasakis pts with >60% of pts < 4 months of age having onset in summer and fall in more. but > 60% of thos over 83 months had onset in winter and spring https://t.co/HAG9ZvQy8A
  4. Sandoz announces the approval of its infliximab biosimilarZessly (infliximab) by the European Commission. It is approved for use in RA, , adult & pediatric Crohn’s, adult & pediatric ulcerative colitis, AS, PsA and plaque psoriasis https://t.co/V0PJHbeLSp
  5. Not all that clear what is the best PFT for pts w/ Scleroderma Lung Disease, Some prefer the FVC, while others advocate for the DLCO or TLC. Do all 3! https://t.co/xNkpgGiYsv
  6. >50% of RA pts fail to receive influenza vaccination (highest in Younger, infrequent visits, Hi ESR, negative vaccine views). The problem was cut in half by using a multimodal intervention (education, EMR alerts, weekly provider-e-mail reminders) https://t.co/H8BxrLVAri
  7. Study of 85 RA patients demonstrates a prothrombotic tendency that is predicted by those with higher DAS-28, CRP, and platelet counts. https://t.co/wqU8XNzIDK
  8. Based on the recommendation of the Data Monitoring Committee, Regeneron has halted its phase III trial of fasinumab (anti- Nerve Growth Factor mAb), in OA pts w/ knee, hip or low back pain. https://t.co/ZwyjJbNzjm
  9. Paul Ridker, MD announced the NIH stopped enrolling the CIRT trial; MTX vs PBO in high risk (non-RA) pts looking at CV outcomes. DSMB rec. stopping after 4,786/7000 enrolled, not for safety, but because of enough efficacy data. Look for results in 11/18 https://t.co/n4PGybItkS
  10. RA pts have a 2 fold risk of osteoporosis-related fractures. High titer CCP levels assoc. w/ lower BMD and lean body mass assoc w/ higher BMD https://t.co/3cxPaiNIn6
  11. FDA Approves Denosumab for Glucocorticoid-Induced Osteoporosis 
  12. MPO Antibodies Predict Relapses in MPO-ANCA-Associated Vasculitis 

 

Disclosures: 
The author has received compensation as an advisor or consultant on this subject

Add new comment

More Like This

The RheumNow Week in Review – EULAR18 Epilogue (6.22.18)

Dr. Jack Cush reviews EULAR 2018 and the past week's news and reports from RheumNow.com, including DMARDs in OA, the price of Penicillamine, Infections when ANCA+, CV outcomes in gout, NSAIDs in Pregnancy and Seropostive vs. Seronegative Outcomes.

CDC Obesity Prevalence Higher in the Rural USA

MMWR reports that approximately 46 million persons (14%) in the United States live in nonmetropolitan counties, where there is a higher prevalence of obesity-associated chronic diseases such as diabetes, coronary heart disease, and arthritis. (Citation source: http://bit.ly/2lj5yql)

EULAR 2018 - Podcast from Day 4

This EULAR 2018 Podcast is a compilation of audio clips from EULAR in Amsterdam.

Click HERE to listen.

You can also listen on iTunes, Soundcloud or Stitcher.

EULAR 2018 - Podcast from Day 3

This EULAR 2018 Podcast is a compilation of audio clips from EULAR in Amsterdam.

Click HERE to listen.

You can also listen on iTunes, Soundcloud or Stitcher. 

The RheumNow Week in Review – EULAR18 Abbreviated (6.15.18)

We're crazy busy at EULAR all week.  Instead of this review, we recommend that you tune into our multiple podcasts from experts and faculty attending EULAR 2018 in Amsterdam.  You can find these on iTunes, SoundCloud or Stitcher.

Tune in next week for the EULAR week in review!